Xelstrym
Payments companies reported to CMS as associated with Xelstrym. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xelstrym, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xelstrym
These are the largest totals companies reported as associated with Xelstrym. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Napoleon Higgins | Friendswood, TX | Psychiatry | $53,582.54 |
| Michelle Holloway | Oklahoma City, OK | Child & Adolescent Psychiatry | $44,627.30 |
| Gregory Mattingley | Saint Charles, MO | Psychiatry | $44,605.81 |
| Birgit Amann | Troy, MI | Child & Adolescent Psychiatry | $39,992.14 |
| Joel Young | Rochester Hills, MI | Psychiatry | $32,631.75 |
| Jennifer Ganem | Londonderry, NH | Psychiatric/Mental Health (Nurse Practitioner) | $31,056.22 |
| Suvrat Bhargave | Tyrone, GA | $27,847.50 | |
| Andrew Cutler | Lakewood Ranch, FL | Psychiatry | $27,831.20 |
| Richard Jackson | Boca Raton, FL | Psychiatry | $23,417.42 |
| Vadim Baram | Saint Louis, MO | Psychiatry | $23,242.29 |
Prescribed Xelstrym?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.